Citation Impact
Citing Papers
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and Continuation Treatment of Major Depressive Disorder
2002
Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report
2006 Standout
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
2006
Dexmedetomidine vs Midazolam for Sedation of Critically Ill Patients<subtitle>A Randomized Trial</subtitle>
2009 Standout
Comparison of pramipexole, fluoxetine, and placebo in patients with major depression
2000
Non-motor symptoms of Parkinson's disease: diagnosis and management
2006 Standout
Blonanserin in the treatment of delirium
2011
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
2009 Standout
Delirium in Elderly Patients and the Risk of Postdischarge Mortality, Institutionalization, and Dementia
2010 Standout
Network pharmacology: the next paradigm in drug discovery
2008 Standout
Pramipexole and pergolide in the treatment of depression in Parkinson's disease: a national multicentre prospective randomized study
2003
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
2009 Standout
Major Depressive Disorder
2008 Standout
Adverse Events Associated with Sedatives, Analgesics, and Other Drugs That Provide Patient Comfort in the Intensive Care Unit
2005
Delirium in the intensive care unit
2009
From the cell to the clinic: A comparative review of the partial D2/D3 receptor agonist and α2-adrenoceptor antagonist, piribedil, in the treatment of Parkinson's disease
2010
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Dopamine D2-Like Receptors and the Antidepressant Response
2006
Works of Kenzo Denda being referenced
Open pergolide treatment of tricyclic and heterocyclic antidepressant-resistant depression
2000
Bromocriptine treatment of tricyclic and heterocyclic antidepressant-resistant depression
1996
A Prospective, Open-Label, Flexible-Dose Study of Quetiapine in the Treatment of Delirium
2003